While many adult patients with asthma are able to generate at least a twofold increase in antibody concentrations in response to immunization, the majority of patients had at least one post-vaccination anti-CP antibody concentration <1 μg/mL, and may not be achieving a threshold associated with clinical protection against IPD. This evidence concerns the gene CP and asthma.